Internal Medicine, Hematology & Oncology · Pasadena, CA
NPI
1609022383
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
50 Alessandro Pl Ste 310
Pasadena, CA, 91105
Phone (626) 288-0008
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
44,341 services
Medicare patients, 2024
554
Average age 75
Drug cost, 2024
$6.6M
1,259 prescriptions
Company payments, 2025
$7,064
From 52 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald Tang was code J0897 (injection, denosumab, 1 mg), 2,226 times for 35 patients. In total Ronald Tang billed 44,341 services in 73 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,226 | 35 | $21.05 | $47K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 884 | 19 | $0.09 | $78.64 |
| 99214 Office E&M - Established | Office | 565 | 311 | $106.00 | $60K |
| 99233 Hospital E&M - Subsequent | Facility | 280 | 99 | $97.36 | $27K |
| 96127 Behavioral Health Services | Office | 215 | 166 | $3.71 | $799 |
| 36415 Venipuncture Blood Collection | Office | 158 | 111 | $8.62 | $1,362 |
| 96372 Injection Administration | Office | 156 | 71 | $12.24 | $1,909 |
| 85025 Blood Count | Office | 144 | 102 | $7.61 | $1,096 |
| 99213 Office E&M - Established | Office | 140 | 94 | $73.87 | $10K |
| 99223 Hospital E&M - Initial | Facility | 135 | 126 | $142.50 | $19K |
| 96413 Chemotherapy Administration | Office | 126 | 29 | $111.25 | $14K |
| 96367 Intravenous Infusion, Hydration | Office | 78 | 21 | $23.86 | $1,861 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 58 | 34 | $0.90 | $52.04 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 56 | 21 | $0.64 | $36.01 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 36 | 12 | $1.02 | $36.57 |
By year: 2022 $129K for 12,939 services; 2023 $320K for 14,084 services; 2024 $1.1M for 44,341 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 158 | 111 | $8.62 | $1,362 |
| 85025 Blood Count | 144 | 102 | $7.61 | $1,096 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald Tang prescribed most often to Medicare patients was Anastrozole, with 70 prescriptions and refills. In total Ronald Tang wrote 1,259 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 70 | 167 | 25 | $939 |
| Letrozole Generic | 60 | 156 | 23 | $1,629 |
| Procrit Epoetin Alfa | 50 | 50 | 12 | $95K |
| Revlimid Lenalidomide | 46 | 46 | Under 11 | $805K |
| Prednisone Generic | 39 | 47 | Under 11 | $211 |
| Lupron Depot Leuprolide Acetate | 36 | 101 | 18 | $200K |
| Ibrance Palbociclib | 36 | 36 | Under 11 | $540K |
| Xtandi Enzalutamide | 35 | 35 | Under 11 | $435K |
| Hydroxyurea Generic | 34 | 88 | 12 | $903 |
| Imbruvica Ibrutinib | 34 | 34 | Under 11 | $555K |
| Exemestane Generic | 34 | 78 | 14 | $5,861 |
| Dexamethasone Generic | 31 | 68 | 13 | $1,016 |
| Abiraterone Acetate Generic | 27 | 27 | Under 11 | $70K |
| Dexamethasone Sodium Phosphate Generic | 25 | 33 | Under 11 | $102 |
| Cabometyx Cabozantinib S-Malate | 25 | 25 | Under 11 | $628K |
Brand drugs: 620 claims; generic drugs: 639 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald Tang $7,064 ($7,064 in general payments such as food, travel and fees) from 52 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,106.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 19 | $1,106 |
| Janssen Biotech, Inc. JNJ | 27 | $859 |
| Merck Sharp & Dohme LLC MRK | 18 | $406 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $336 |
| Incyte Corporation INCY | 12 | $302 |
| Celgene Corporation BMY | 21 | $299 |
| Gilead Sciences, Inc. GILD | 13 | $263 |
| Genentech USA, Inc. ROG.SW | 12 | $230 |
| Exelixis Inc. EXEL | 8 | $224 |
| Daiichi Sankyo Inc. 4568.T | 10 | $211 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.